Medacta Group S.A.
0A05.L
Get informed when a big investor buys or sells
+ FollowMarket Cap$2.74B
Close$
$95.10
16.4% downside
Current Fair Value
16.4% downsideOvervalued by 16.4% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.74 Billion |
|---|---|
| Enterprise Value | $3.03 Billion |
| Dividend Yield | $1.10 (0.96%) |
| Earnings per Share | $4.81 |
| Beta | 0.99 |
| Outstanding Shares | 19,926,287 |
Return
| Return on Equity | 35.51% |
|---|---|
| Return on Assets | 17.02% |
| Return on Invested Capital | 28.35% |
Valuation & Multiples
| P/E Ratio | 31.55 |
|---|---|
| PEG | -103.07 |
| Price to Sales | 1.7 |
| Price to Book Ratio | 4.74 |
| Enterprise Value to Revenue | 2.24 |
| Enterprise Value to EBIT | 13.79 |
| Enterprise Value to Net Income | 17 |
| Total Debt to Enterprise | 0.11 |
| Debt to Equity | 0.66 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
September 9, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
$341.76 M
Average shareholder expectationNext Earnings Call
Expected Date
March 12, 2027
EPS Estimate
$2.51
Average shareholder expectationRevenue Estimate
$355.94 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Medacta Group S.A.
2,165 employees
CEO: Francesco Siccardi Medacta Group SA is a global provider specializing in the development, production, and distribution of orthopedic and neurosurgical medical devices. The company's operations span across Europe, North America, the Asia-Pacific region, and...